Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cyclin-dependent kinase 1 (CDK1) is a highly conserved serine/threonine protein kinase that plays a central role in regulating the eukaryotic cell cycle. It is essential for the control of both mitosis and meiosis, driving transitions between key phases of the cell cycle. CDK1 forms complexes with various cyclins—most notably cyclin B—to create the M-phase promoting factor (MPF), which is crucial for progression from G2 to M phase. Overexpression or dysregulation of CDK1 has been implicated in various cancers, and inhibition of CDK1 is being explored therapeutically.
Phosphorylation of numerous substrates (>75 identified in yeast) involved in orchestrating cellular events required for successful mitosis/meiosis.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclin-dependent kinase 1 (CDK1).